Evaluation of the Food and Drug Administration's General Market Youth Tobacco Prevention Campaign

The Food and Drug Administration (FDA) requests Office of Management and Budget (OMB) approval to conduct in-person and Web-based surveys of youth in targeted areas in the United States. These surveys will be fielded for purposes of evaluating FDA's general market youth tobacco prevention campaigns. The primary outcome evaluation will consist of an initial baseline survey before the launch of each of three campaigns and three longitudinal follow-up surveys of those participants in 8-month intervals following the baseline data collection. In addition, a tracking survey to assess awareness of the campaigns and receptivity to campaign messages will occur in 8-month intervals throughout the data collection period. As part of the outcome evaluation study, a baseline survey will also be conducted with the parent or legal guardian of each youth baseline survey participant in order to collect data on household characteristics and media use. Data from this evaluation will be used to gauge campaign awareness and examine the statistical relationships between exposure to the campaigns and changes in outcome variables of interest.

The latest form for Evaluation of the Food and Drug Administration's General Market Youth Tobacco Prevention Campaign expires 2023-01-31 and is listed under ICR 202009-0910-008.

General Population Screener and Consent Process (Youth and Parent)

Federal Enterprise Architecture: Health - Consumer Health and Safety